<?xml version="1.0" ?>
<TimeML xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="http://timeml.org/timeMLdocs/TimeML_1.2.1.xsd">

<DOCID>695197510184</DOCID>

<DCT><TIMEX3 tid="t0" type="DATE" value="20170129" temporalFunction="false" functionInDocument="CREATION_TIME">January 29, 2017</TIMEX3></DCT>

<TITLE>Parasite protein could help inform new anti-tuberculosis strategies</TITLE>


<TEXT>
Schematic model for the roles of GRA7 and GRA7-mediated regulatory pathways against intracellular pathogens such as Mycobacteria and T. gondii. Credit: Koh et al., Hanyang University, S. KOREA. 

Proteins produced by the parasite that causes toxoplasmosis may be <EVENT eid="e1" class="OCCURRENCE">involved</EVENT> in immune system processes that can <EVENT eid="e2" class="I_STATE">help fight</EVENT> mycobacteria, according to a new study. The findings, published in PLOS Pathogens, <EVENT eid="e3" class="REPORTING">suggest</EVENT> that these proteins could potentially <EVENT eid="e4" class="OCCURRENCE">play</EVENT> a role in new treatment strategies for tuberculosis. 

Tuberculosis <EVENT eid="e5" class="STATE">infects</EVENT> millions worldwide and <EVENT eid="e6" class="OCCURRENCE">kills</EVENT> over two million people <TIMEX3 tid="t1" type="DATE" value="X">each</TIMEX3> year, mostly in low-and middle-income countries. To <EVENT eid="e7" class="OCCURRENCE">improve</EVENT> treatment strategies, scientists have <EVENT eid="e8" class="OCCURRENCE">proposed</EVENT> the use of host-directed therapies, which target processes in the human body that help mycobacteria <EVENT eid="e9" class="OCCURRENCE">survive</EVENT> and <EVENT eid="e10" class="OCCURRENCE">thrive</EVENT>, rather than directly <EVENT eid="e11" class="OCCURRENCE">targeting</EVENT> the bacteria themselves. 

In the new study, Hyun-Jung Koh and colleagues at Hanyang University in South Korea <EVENT eid="e12" class="I_STATE">suggest</EVENT> that proteins produced by a different pathogen, the parasite that <EVENT eid="e13" class="OCCURRENCE">causes</EVENT> the disease toxoplasmosis, could <EVENT eid="e14" class="OCCURRENCE">play</EVENT> a role in the <EVENT eid="e15" class="OCCURRENCE">development</EVENT> of host-directed tuberculosis therapies. 

The scientists <EVENT eid="e16" class="REPORTING">reported</EVENT> that mycobacteria-infected mice and human cell lines were <EVENT eid="e17" class="OCCURRENCE">treated</EVENT> with recombinant GRA7 to <EVENT eid="e18" class="OCCURRENCE">investigate</EVENT> the activity of GRA7 proteins, which are produced by the parasites after they <EVENT eid="e19" class="OCCURRENCE">infect</EVENT> a host cell. They <EVENT eid="e20" class="REPORTING">found</EVENT> that a host protein <EVENT eid="e21" class="OCCURRENCE">called</EVENT> PKC is essential for <EVENT eid="e22" class="OCCURRENCE">interactions</EVENT> between GRA7 and host proteins known as ASC and PLD1. 

These <EVENT eid="e23" class="OCCURRENCE">interactions</EVENT> are <EVENT eid="e24" class="I_STATE">known</EVENT> to <EVENT eid="e25" class="OCCURRENCE">contribute</EVENT> to anti-tuberculosis defense mechanisms, <EVENT eid="e26" class="OCCURRENCE">suggesting</EVENT> the potential for <EVENT eid="e27" class="OCCURRENCE">development</EVENT> of GRA7-based host-directed tuberculosis therapies. However, this study was <EVENT eid="e28" class="OCCURRENCE">performed</EVENT> in mice and human cells, not in tuberculosis patients, and further research is <EVENT eid="e29" class="I_STATE">needed</EVENT> to better <EVENT eid="e30" class="OCCURRENCE">understand</EVENT> the molecular role of GRA7 in humans. 

More information: Koh H-J, Kim Y-R, Kim J-S, Yun J-S, Jang K, Yang C-S (<TIMEX3 tid="t2" type="DATE" value="2017">2017</TIMEX3>) Toxoplasma gondii GRA7-Targeted ASC and PLD1 Promote Antibacterial Host Defense via PKC. PLoS Pathog 13(1): e1006126. DOI: 10.1371/journal.ppat.1006126 

Provided by: Public Library of Science 

Explore further 

Cleverly designed tuberculosis vaccine shows promise in mice 

<TIMEX3 tid="t3" type="DATE" value="2017-01-13">Jan 13, 2017</TIMEX3> 

A clever new tuberculosis vaccine has <EVENT eid="e31" class="OCCURRENCE">shown</EVENT> promise in trials in mice. If it <EVENT eid="e32" class="OCCURRENCE">succeeds</EVENT>, it will be the first new TB vaccine in a century. With the <EVENT eid="e33" class="OCCURRENCE">rise</EVENT> of multidrug resistant tuberculosis, the difficulty of curing the disease, ... 

Scientists <EVENT eid="e34" class="STATE">identify</EVENT> protein central to immune <EVENT eid="e35" class="OCCURRENCE">response</EVENT> against tuberculosis bacteria 

<TIMEX3 tid="t4" type="DATE" value="2017-01-12">Jan 12, 2017</TIMEX3> 

UT Southwestern Medical Center researchers have <EVENT eid="e36" class="OCCURRENCE">identified</EVENT> a protein that is central to the immune system's ability to <EVENT eid="e37" class="OCCURRENCE">recognize</EVENT> and <EVENT eid="e38" class="OCCURRENCE">destroy</EVENT> the bacterium responsible for the global tuberculosis (TB) epidemic.The new finding, ... 

Toward an effective TB vaccine: Analysis of the immune response to a promising candidate 

<TIMEX3 tid="t5" type="DATE" value="2016-07-28">Jul 28, 2016</TIMEX3> 

BCG, the only currently <EVENT eid="e39" class="STATE">approved</EVENT> TB vaccine, has been around for almost <TIMEX3 tid="t6" type="DATE" value="X">a century</TIMEX3> and is only partially effective. When given to children, BCG is <EVENT eid="e40" class="I_STATE">estimated</EVENT> to <EVENT eid="e41" class="STATE">prevent</EVENT> 20% of infections and to <EVENT eid="e42" class="OCCURRENCE">protect</EVENT> half of the infected ... 

Scientists explain why Russian tuberculosis is the most infectious 

<TIMEX3 tid="t7" type="DATE" value="2017-08-22">Aug 22</TIMEX3>, <TIMEX3 tid="t8" type="DATE" value="2016">2016</TIMEX3> 

A collaborative of Russian researchers <EVENT eid="e43" class="OCCURRENCE">conducted</EVENT> a large-scale analysis of the proteins and genomes of mycobacterium tuberculosis strains that are common in Russia and countries of the former Soviet Union and <EVENT eid="e44" class="OCCURRENCE">found</EVENT> features ... 

How our immune system <EVENT eid="e45" class="OCCURRENCE">targets</EVENT> tuberculosis 

<TIMEX3 tid="t9" type="DATE" value="2016-12-07">Dec 07, 2016   Every 18</TIMEX3> seconds someone <EVENT eid="e46" class="OCCURRENCE">dies</EVENT> from tuberculosis (TB). It is the world's most deadly infectious disease.
</TEXT>


<MAKEINSTANCE eiid="ie44" eventID="e44" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie39" eventID="e39" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie38" eventID="e38" pos="VERB" tense="INFINITIVE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie19" eventID="e19" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie18" eventID="e18" pos="VERB" tense="INFINITIVE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie35" eventID="e35" pos="NOUN" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie34" eventID="e34" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie33" eventID="e33" pos="NOUN" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie32" eventID="e32" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie31" eventID="e31" pos="VERB" tense="PRESENT" aspect="PERFECTIVE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie30" eventID="e30" pos="UNKNOWN" tense="INFINITIVE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie11" eventID="e11" pos="VERB" tense="PRESPART" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie10" eventID="e10" pos="NOUN" tense="INFINITIVE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie13" eventID="e13" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie12" eventID="e12" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie15" eventID="e15" pos="NOUN" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie14" eventID="e14" pos="UNKNOWN" tense="FUTURE" aspect="NONE" polarity="NEG" modality="N/A" />
<MAKEINSTANCE eiid="ie17" eventID="e17" pos="UNKNOWN" tense="PAST" aspect="NONE" polarity="NEG" modality="N/A" />
<MAKEINSTANCE eiid="ie16" eventID="e16" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie42" eventID="e42" pos="VERB" tense="INFINITIVE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie37" eventID="e37" pos="VERB" tense="INFINITIVE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie36" eventID="e36" pos="UNKNOWN" tense="PRESENT" aspect="PERFECTIVE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie40" eventID="e40" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie43" eventID="e43" pos="UNKNOWN" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie41" eventID="e41" pos="VERB" tense="INFINITIVE" aspect="NONE" polarity="NEG" modality="N/A" />
<MAKEINSTANCE eiid="ie9" eventID="e9" pos="VERB" tense="PRESENT" aspect="NONE" polarity="NEG" modality="N/A" />
<MAKEINSTANCE eiid="ie8" eventID="e8" pos="UNKNOWN" tense="PRESENT" aspect="PERFECTIVE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie5" eventID="e5" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie4" eventID="e4" pos="UNKNOWN" tense="FUTURE" aspect="NONE" polarity="NEG" modality="N/A" />
<MAKEINSTANCE eiid="ie7" eventID="e7" pos="VERB" tense="INFINITIVE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie6" eventID="e6" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie1" eventID="e1" pos="UNKNOWN" tense="NONE" aspect="NONE" polarity="POS" modality="NONE" />
<MAKEINSTANCE eiid="ie3" eventID="e3" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie2" eventID="e2" pos="VERB" tense="NONE" aspect="NONE" polarity="POS" modality="COULD" />
<MAKEINSTANCE eiid="ie24" eventID="e24" pos="ADJECTIVE" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie25" eventID="e25" pos="VERB" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie26" eventID="e26" pos="VERB" tense="PRESPART" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie27" eventID="e27" pos="NOUN" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie20" eventID="e20" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie21" eventID="e21" pos="VERB" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie22" eventID="e22" pos="NOUN" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie23" eventID="e23" pos="NOUN" tense="NONE" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie46" eventID="e46" pos="UNKNOWN" tense="PRESENT" aspect="NONE" polarity="NEG" modality="N/A" />
<MAKEINSTANCE eiid="ie45" eventID="e45" pos="VERB" tense="PRESENT" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie28" eventID="e28" pos="UNKNOWN" tense="PAST" aspect="NONE" polarity="POS" modality="N/A" />
<MAKEINSTANCE eiid="ie29" eventID="e29" pos="VERB" tense="PRESENT" aspect="PERFECTIVE" polarity="POS" modality="N/A" />

<TLINK lid="TL1" eventInstanceID="ie37" relatedToEventInstance="ie38" relType="SIMULTANEOUS" />
<TLINK lid="TL9" timeID="t5" relatedToEventInstance="ie36" relType="INCLUDES" />
<TLINK lid="TL5" eventInstanceID="ie29" relatedToEventInstance="ie30" relType="AFTER" />
<TLINK lid="TL13" timeID="t4" relatedToEventInstance="ie36" relType="INCLUDES" />
<TLINK lid="TL11" timeID="t4" relatedToEventInstance="ie35" relType="INCLUDES" />
<TLINK lid="TL10" timeID="t8" relatedToEventInstance="ie43" relType="INCLUDES" />
<TLINK lid="TL0" eventInstanceID="ie33" relatedToEventInstance="ie35" relType="IDENTITY" />
<TLINK lid="TL3" eventInstanceID="ie46" relatedToTime="t9" relType="IS_INCLUDED" />
<TLINK lid="TL8" timeID="t5" relatedToEventInstance="ie34" relType="INCLUDES" />
<TLINK lid="TL7" timeID="t5" relatedToEventInstance="ie35" relType="INCLUDES" />
<TLINK lid="TL2" eventInstanceID="ie8" relatedToEventInstance="ie7" relType="AFTER" />
<TLINK lid="TL4" eventInstanceID="ie45" relatedToTime="t9" relType="IS_INCLUDED" />
<TLINK lid="TL6" timeID="t5" relatedToEventInstance="ie39" relType="INCLUDES" />
<TLINK lid="TL12" timeID="t4" relatedToEventInstance="ie34" relType="INCLUDES" />
</TimeML>
